1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Short Bowel Syndrome (SBS) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Route
1.2.3 Parental Route
1.3 Market by Application
1.3.1 Global Short Bowel Syndrome (SBS) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Short Bowel Syndrome (SBS) Market Perspective (2016-2027)
2.2 Short Bowel Syndrome (SBS) Growth Trends by Regions
2.2.1 Short Bowel Syndrome (SBS) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Short Bowel Syndrome (SBS) Historic Market Share by Regions (2016-2021)
2.2.3 Short Bowel Syndrome (SBS) Forecasted Market Size by Regions (2022-2027)
2.3 Short Bowel Syndrome (SBS) Industry Dynamic
2.3.1 Short Bowel Syndrome (SBS) Market Trends
2.3.2 Short Bowel Syndrome (SBS) Market Drivers
2.3.3 Short Bowel Syndrome (SBS) Market Challenges
2.3.4 Short Bowel Syndrome (SBS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Short Bowel Syndrome (SBS) Players by Revenue
3.1.1 Global Top Short Bowel Syndrome (SBS) Players by Revenue (2016-2021)
3.1.2 Global Short Bowel Syndrome (SBS) Revenue Market Share by Players (2016-2021)
3.2 Global Short Bowel Syndrome (SBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Short Bowel Syndrome (SBS) Revenue
3.4 Global Short Bowel Syndrome (SBS) Market Concentration Ratio
3.4.1 Global Short Bowel Syndrome (SBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Short Bowel Syndrome (SBS) Revenue in 2020
3.5 Short Bowel Syndrome (SBS) Key Players Head office and Area Served
3.6 Key Players Short Bowel Syndrome (SBS) Product Solution and Service
3.7 Date of Enter into Short Bowel Syndrome (SBS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Short Bowel Syndrome (SBS) Breakdown Data by Type
4.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Type (2016-2021)
4.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Type (2022-2027)
5 Short Bowel Syndrome (SBS) Breakdown Data by Application
5.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Application (2016-2021)
5.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Short Bowel Syndrome (SBS) Market Size (2016-2027)
6.2 North America Short Bowel Syndrome (SBS) Market Size by Type
6.2.1 North America Short Bowel Syndrome (SBS) Market Size by Type (2016-2021)
6.2.2 North America Short Bowel Syndrome (SBS) Market Size by Type (2022-2027)
6.2.3 North America Short Bowel Syndrome (SBS) Market Size by Type (2016-2027)
6.3 North America Short Bowel Syndrome (SBS) Market Size by Application
6.3.1 North America Short Bowel Syndrome (SBS) Market Size by Application (2016-2021)
6.3.2 North America Short Bowel Syndrome (SBS) Market Size by Application (2022-2027)
6.3.3 North America Short Bowel Syndrome (SBS) Market Size by Application (2016-2027)
6.4 North America Short Bowel Syndrome (SBS) Market Size by Country
6.4.1 North America Short Bowel Syndrome (SBS) Market Size by Country (2016-2021)
6.4.2 North America Short Bowel Syndrome (SBS) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Short Bowel Syndrome (SBS) Market Size (2016-2027)
7.2 Europe Short Bowel Syndrome (SBS) Market Size by Type
7.2.1 Europe Short Bowel Syndrome (SBS) Market Size by Type (2016-2021)
7.2.2 Europe Short Bowel Syndrome (SBS) Market Size by Type (2022-2027)
7.2.3 Europe Short Bowel Syndrome (SBS) Market Size by Type (2016-2027)
7.3 Europe Short Bowel Syndrome (SBS) Market Size by Application
7.3.1 Europe Short Bowel Syndrome (SBS) Market Size by Application (2016-2021)
7.3.2 Europe Short Bowel Syndrome (SBS) Market Size by Application (2022-2027)
7.3.3 Europe Short Bowel Syndrome (SBS) Market Size by Application (2016-2027)
7.4 Europe Short Bowel Syndrome (SBS) Market Size by Country
7.4.1 Europe Short Bowel Syndrome (SBS) Market Size by Country (2016-2021)
7.4.2 Europe Short Bowel Syndrome (SBS) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size (2016-2027)
8.2 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type
8.2.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type (2016-2027)
8.3 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application
8.3.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application (2016-2027)
8.4 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region
8.4.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Short Bowel Syndrome (SBS) Market Size (2016-2027)
9.2 Latin America Short Bowel Syndrome (SBS) Market Size by Type
9.2.1 Latin America Short Bowel Syndrome (SBS) Market Size by Type (2016-2021)
9.2.2 Latin America Short Bowel Syndrome (SBS) Market Size by Type (2022-2027)
9.2.3 Latin America Short Bowel Syndrome (SBS) Market Size by Type (2016-2027)
9.3 Latin America Short Bowel Syndrome (SBS) Market Size by Application
9.3.1 Latin America Short Bowel Syndrome (SBS) Market Size by Application (2016-2021)
9.3.2 Latin America Short Bowel Syndrome (SBS) Market Size by Application (2022-2027)
9.3.3 Latin America Short Bowel Syndrome (SBS) Market Size by Application (2016-2027)
9.4 Latin America Short Bowel Syndrome (SBS) Market Size by Country
9.4.1 Latin America Short Bowel Syndrome (SBS) Market Size by Country (2016-2021)
9.4.2 Latin America Short Bowel Syndrome (SBS) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size (2016-2027)
10.2 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type
10.2.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type (2016-2027)
10.3 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application
10.3.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application (2016-2027)
10.4 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country
10.4.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Short Bowel Syndrome (SBS) Introduction
11.1.4 Merck Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Short Bowel Syndrome (SBS) Introduction
11.2.4 Takeda Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.2.5 Takeda Recent Development
11.3 Emmaus Medical
11.3.1 Emmaus Medical Company Details
11.3.2 Emmaus Medical Business Overview
11.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Introduction
11.3.4 Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.3.5 Emmaus Medical Recent Development
11.4 Ardelyx
11.4.1 Ardelyx Company Details
11.4.2 Ardelyx Business Overview
11.4.3 Ardelyx Short Bowel Syndrome (SBS) Introduction
11.4.4 Ardelyx Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.4.5 Ardelyx Recent Development
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Details
11.5.2 Naia Pharmaceuticals Business Overview
11.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Introduction
11.5.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.5.5 Naia Pharmaceuticals Recent Development
11.6 Nutrinia
11.6.1 Nutrinia Company Details
11.6.2 Nutrinia Business Overview
11.6.3 Nutrinia Short Bowel Syndrome (SBS) Introduction
11.6.4 Nutrinia Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.6.5 Nutrinia Recent Development
11.7 OxThera
11.7.1 OxThera Company Details
11.7.2 OxThera Business Overview
11.7.3 OxThera Short Bowel Syndrome (SBS) Introduction
11.7.4 OxThera Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.7.5 OxThera Recent Development
11.8 Sancilio Pharmaceuticals
11.8.1 Sancilio Pharmaceuticals Company Details
11.8.2 Sancilio Pharmaceuticals Business Overview
11.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Introduction
11.8.4 Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.8.5 Sancilio Pharmaceuticals Recent Development
11.9 Zealand Pharma
11.9.1 Zealand Pharma Company Details
11.9.2 Zealand Pharma Business Overview
11.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Introduction
11.9.4 Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.9.5 Zealand Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Short Bowel Syndrome (SBS) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Route
Table 3. Key Players of Parental Route
Table 4. Global Short Bowel Syndrome (SBS) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Short Bowel Syndrome (SBS) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Short Bowel Syndrome (SBS) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Short Bowel Syndrome (SBS) Market Share by Regions (2016-2021)
Table 8. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Short Bowel Syndrome (SBS) Market Share by Regions (2022-2027)
Table 10. Short Bowel Syndrome (SBS) Market Trends
Table 11. Short Bowel Syndrome (SBS) Market Drivers
Table 12. Short Bowel Syndrome (SBS) Market Challenges
Table 13. Short Bowel Syndrome (SBS) Market Restraints
Table 14. Global Short Bowel Syndrome (SBS) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Short Bowel Syndrome (SBS) Market Share by Players (2016-2021)
Table 16. Global Top Short Bowel Syndrome (SBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome (SBS) as of 2020)
Table 17. Ranking of Global Top Short Bowel Syndrome (SBS) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Short Bowel Syndrome (SBS) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Short Bowel Syndrome (SBS) Product Solution and Service
Table 21. Date of Enter into Short Bowel Syndrome (SBS) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2016-2021)
Table 25. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Short Bowel Syndrome (SBS) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Short Bowel Syndrome (SBS) Revenue Market Share by Application (2016-2021)
Table 29. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Short Bowel Syndrome (SBS) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Short Bowel Syndrome (SBS) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Short Bowel Syndrome (SBS) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Short Bowel Syndrome (SBS) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Short Bowel Syndrome (SBS) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Short Bowel Syndrome (SBS) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Short Bowel Syndrome (SBS) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Short Bowel Syndrome (SBS) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Short Bowel Syndrome (SBS) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Short Bowel Syndrome (SBS) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Short Bowel Syndrome (SBS) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Short Bowel Syndrome (SBS) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Short Bowel Syndrome (SBS) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Short Bowel Syndrome (SBS) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Short Bowel Syndrome (SBS) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Short Bowel Syndrome (SBS) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Short Bowel Syndrome (SBS) Product
Table 64. Merck Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Takeda Company Details
Table 67. Takeda Business Overview
Table 68. Takeda Short Bowel Syndrome (SBS) Product
Table 69. Takeda Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 70. Takeda Recent Development
Table 71. Emmaus Medical Company Details
Table 72. Emmaus Medical Business Overview
Table 73. Emmaus Medical Short Bowel Syndrome (SBS) Product
Table 74. Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 75. Emmaus Medical Recent Development
Table 76. Ardelyx Company Details
Table 77. Ardelyx Business Overview
Table 78. Ardelyx Short Bowel Syndrome (SBS) Product
Table 79. Ardelyx Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 80. Ardelyx Recent Development
Table 81. Naia Pharmaceuticals Company Details
Table 82. Naia Pharmaceuticals Business Overview
Table 83. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Product
Table 84. Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 85. Naia Pharmaceuticals Recent Development
Table 86. Nutrinia Company Details
Table 87. Nutrinia Business Overview
Table 88. Nutrinia Short Bowel Syndrome (SBS) Product
Table 89. Nutrinia Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 90. Nutrinia Recent Development
Table 91. OxThera Company Details
Table 92. OxThera Business Overview
Table 93. OxThera Short Bowel Syndrome (SBS) Product
Table 94. OxThera Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 95. OxThera Recent Development
Table 96. Sancilio Pharmaceuticals Company Details
Table 97. Sancilio Pharmaceuticals Business Overview
Table 98. Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 99. Sancilio Pharmaceuticals Recent Development
Table 100. Zealand Pharma Company Details
Table 101. Zealand Pharma Business Overview
Table 102. Zealand Pharma Short Bowel Syndrome (SBS) Product
Table 103. Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 104. Zealand Pharma Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Short Bowel Syndrome (SBS) Market Share by Type: 2020 VS 2027
Figure 2. Oral Route Features
Figure 3. Parental Route Features
Figure 4. Global Short Bowel Syndrome (SBS) Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Short Bowel Syndrome (SBS) Report Years Considered
Figure 9. Global Short Bowel Syndrome (SBS) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Short Bowel Syndrome (SBS) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Short Bowel Syndrome (SBS) Market Share by Regions: 2020 VS 2027
Figure 12. Global Short Bowel Syndrome (SBS) Market Share by Regions (2022-2027)
Figure 13. Global Short Bowel Syndrome (SBS) Market Share by Players in 2020
Figure 14. Global Top Short Bowel Syndrome (SBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome (SBS) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Short Bowel Syndrome (SBS) Revenue in 2020
Figure 16. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2016-2021)
Figure 17. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2022-2027)
Figure 18. North America Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Short Bowel Syndrome (SBS) Market Share by Type (2016-2027)
Figure 20. North America Short Bowel Syndrome (SBS) Market Share by Application (2016-2027)
Figure 21. North America Short Bowel Syndrome (SBS) Market Share by Country (2016-2027)
Figure 22. United States Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Short Bowel Syndrome (SBS) Market Share by Type (2016-2027)
Figure 26. Europe Short Bowel Syndrome (SBS) Market Share by Application (2016-2027)
Figure 27. Europe Short Bowel Syndrome (SBS) Market Share by Country (2016-2027)
Figure 28. Germany Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Short Bowel Syndrome (SBS) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Short Bowel Syndrome (SBS) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Short Bowel Syndrome (SBS) Market Share by Region (2016-2027)
Figure 38. China Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Short Bowel Syndrome (SBS) Market Share by Type (2016-2027)
Figure 46. Latin America Short Bowel Syndrome (SBS) Market Share by Application (2016-2027)
Figure 47. Latin America Short Bowel Syndrome (SBS) Market Share by Country (2016-2027)
Figure 48. Mexico Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Short Bowel Syndrome (SBS) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Short Bowel Syndrome (SBS) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Short Bowel Syndrome (SBS) Market Share by Country (2016-2027)
Figure 54. Turkey Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 58. Takeda Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 59. Emmaus Medical Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 60. Ardelyx Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 61. Naia Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 62. Nutrinia Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 63. OxThera Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 64. Sancilio Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 65. Zealand Pharma Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
【掲載企業】
Merck、Takeda、Emmaus Medical、Ardelyx、Naia Pharmaceuticals、Nutrinia、OxThera、Sancilio Pharmaceuticals、Zealand Pharma